Personal information

No personal information available

Activities

Works (4)

Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in a newly diagnosed multiple myeloma

Clinical Case Reports
2024-01 | Journal article
Contributors: Juan José Gil‐Fernández; Patricia García Ramírez; Marta Callejas Charavía
Source: check_circle
Crossref

[Ca-125 as a tumor marker in a patient with non Hodgkins lymphoma].

Medicina clinica
2002-07 | Journal article
Contributors: José Gil-Fernández J; Tamayo AT; Pérez MA; Fernández-Rañada JM
Source: Self-asserted source
JUAN JOSE GIL FERNANDEZ via Europe PubMed Central

Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution.

Bone marrow transplantation
1996-11 | Journal article
PMID: 8932847
Contributors: Gil-Fernández JJ; Alegre A; Fernández-Villalta MJ; Pinilla I; Gómez García V; Martinez C; Tomás JF; Arranz R; Figuera A; Cámara R et al.
Source: Self-asserted source
JUAN JOSE GIL FERNANDEZ via Europe PubMed Central

Quinton-Mahurkar catheter as short-term central venous access for PBSC collection: single-center experience of 370 aphereses in 110 patients.

Bone marrow transplantation
1996-11 | Journal article
PMID: 8932838
Contributors: Alegre A; Requena MJ; Fernández-Villalta MJ; Orts M; Gilsanz F; Tomás JF; Arranz R; Gil-Fernández JJ; Granda A; Bernardo MR et al.
Source: Self-asserted source
JUAN JOSE GIL FERNANDEZ via Europe PubMed Central